SOLENO THERAPEUTICS

SOLENO THERAPEUTICS

Share · US8342033094 · SLNO (LSSI)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of SOLENO THERAPEUTICS
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
8
5
0
0
No Price
29.04.2026 05:27
Current Prices from SOLENO THERAPEUTICS
ExchangeTickerCurrencyLast TradePriceDaily Change
XDQU: Quotrix
Quotrix
STIRSD94.DUSD
EUR
29.04.2026 05:27
44,85 EUR
-0,08 EUR
-0,18 %
XNAS: NASDAQ
NASDAQ
SLNO
USD
28.04.2026 20:40
52,71 USD
-0,04 USD
-0,08 %
IEXG: IEX
IEX
SLNO
USD
28.04.2026 19:59
52,77 USD
0,02 USD
+0,04 %
XDUS: Düsseldorf
Düsseldorf
STIRSD94.DUSB
EUR
28.04.2026 17:31
44,81 EUR
-0,12 EUR
-0,27 %
Share Float & Liquidity
Free Float 95,78 %
Shares Float 49,53 M
Shares Outstanding 51,72 M
Company Profile for SOLENO THERAPEUTICS Share
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

Company Data

Name SOLENO THERAPEUTICS
Company Soleno Therapeutics, Inc.
Symbol SLNO
Website https://soleno.life
Primary Exchange LSSI Lang & Schwarz
ISIN US8342033094
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Anish Bhatnagar
Market Capitalization 3 Mrd.
Country United States of America
Currency EUR
Employees 0,1 T
Address 203 Redwood Shores Parkway, 94065 Redwood City
IPO Date 2014-11-13

Stock Splits

Date Split
26.08.2022 1:15
06.10.2017 1:5

ID Changes

Date From To
18.05.2017 CAPN SLNO

Ticker Symbols

Name Symbol
Düsseldorf STIRSD94.DUSB
Frankfurt 6XC.F
NASDAQ SLNO
Quotrix STIRSD94.DUSD
More Shares
Investors who hold SOLENO THERAPEUTICS also have the following shares in their portfolio:
EURONET WW. 19/26
EURONET WW. 19/26 Bond
SKF 21/31
SKF 21/31 Bond